Definitive Healthcare Corp.
DH Nasdaq
SEC CIK 1861795
Follow Definitive Healthcare Corp.
Weekly email: filings, results
Revenue, last quarter
$54.7M
−9% vs same quarter last year
Net income
−$3.9M
+73.8% vs same quarter last year
EPS, diluted
−$0.04
+71.4% vs same quarter last year
Operating cash flow
$11.4M
−27.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $241.5M | −$138.9M |
| FY24 | $252.2M | −$413.1M |
| FY23 | $251.4M | −$202.4M |
| FY22 | $222.7M | −$7.2M |
| FY21 | $166.2M | −$17.8M |
| FY20 | $118.3M | $0 |
| FY19 | - | - |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 75.9% | −92.9% | −57.5% |
| FY24 | 78.3% | −281.8% | −163.8% |
| FY23 | 81.1% | −131.2% | −80.5% |
| FY22 | 80.9% | −19.8% | −3.2% |
| FY21 | 75.5% | −16.4% | −10.7% |
| FY20 | 74.2% | −13.4% | 0% |
| FY19 | - | - | - |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $37.1M |
| FY24 | $45.9M |
| FY23 | $38.2M |
| FY22 | $27.3M |
| FY21 | $18.5M |
| FY20 | $21.8M |
| FY19 | - |
| FY18 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $49.5M |
| FY24 | $22.4M |
| FY23 | $0 |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
- Definitive Healthcare Corp.
- Technology median
Show the numbers
| Year | Definitive Healthcare Corp. | Technology median |
|---|---|---|
| FY25 | −57.5% | −2.4% |
| FY24 | −163.8% | −5% |
| FY23 | −80.5% | −6.7% |
| FY22 | −3.2% | −4.4% |
| FY21 | −10.7% | −1.7% |
| FY20 | 0% | −3% |
| FY19 | - | 0% |
| FY18 | - | 0.8% |